Meditope-Enabled Chimeric Antigen Receptors Facilitate Plug-and-Play Control of T Cells
Cheng-Fu Kuo, Zhen Tong, Yi‐Chiu Kuo, Miso Park, Jeremy D. King, Kevin Ly, Bea Parcutela, Lawrence A. Stern, Zhiqiang Wang, Jonathan C. Hibbard, Brenda Aguilar, Renate Starr, Wen-Chung Chang, Julie R. Ostberg, Daniel J. Rossi, , Christine E. Brown
This study develops meditope-enabled CARs to improve T cell functionality and address tumor heterogeneity in CAR therapy.
Cancer Immunology Research · Aug 4, 2026Peer-reviewedBioengineering